Court Place Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Court Place Advisors, LLC

$341 Million
Q3 2024

A detailed history of Court Place Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Court Place Advisors, LLC holds 13,483 shares of LGND stock, worth $1.47 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

13,483

Previous 3,317 306.48%

Holding current value

$1.47 Million

Previous $332,000 306.63%

% of portfolio

0.4%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$82.7 - $110.11 $840,728 - $1.12 Million	10,166 Added 306.48%	13,483 $1.35 Million
Q3 2024 Oct 23, 2024	SELL	$82.7 - $110.11 $900,685 - $1.2 Million	-10,891 Reduced 76.65%	3,317 $332,000
Q2 2024 Jul 31, 2024	BUY	$68.53 - $87.91 $443,731 - $569,217	6,475 Added 83.73%	14,208 $1.2 Million
Q1 2024 Apr 26, 2024	SELL	$68.64 - $89.2 $501,072 - $651,160	-7,300 Reduced 48.56%	7,733 $565,000
Q4 2023 Jan 31, 2024	SELL	$49.57 - $72.63 $4,957 - $7,263	-100 Reduced 0.66%	15,033 $1.07 Million
Q2 2023 Aug 01, 2023	SELL	$69.53 - $79.33 $27,812 - $31,732	-400 Reduced 2.58%	15,133 $1.09 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $2 - $21,512	-200 Reduced 1.27%	15,533 $1.34 Million
Q3 2021 Nov 12, 2021	SELL	$102.33 - $144.73 $11,767 - $16,643	-115 Reduced 0.73%	15,733 $2.19 Million
Q2 2021 Aug 12, 2021	SELL	$113.03 - $155.64 $11,303 - $15,563	-100 Reduced 0.63%	15,848 $2.08 Million
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $29,856 - $64,749	-300 Reduced 1.85%	15,948 $2.43 Million
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $8,055 - $10,605	-100 Reduced 0.61%	16,248 $1.62 Million
Q3 2020 Oct 26, 2020	BUY	$89.56 - $126.72 $101,023 - $142,940	1,128 Added 7.41%	16,348 $1.56 Million
Q2 2020 Aug 05, 2020	SELL	$68.28 - $123.65 $10,242 - $18,547	-150 Reduced 0.98%	15,220 $1.7 Million
Q1 2020 May 05, 2020	SELL	$63.37 - $107.88 $4,435 - $7,551	-70 Reduced 0.45%	15,370 $1.12 Million
Q3 2019 Oct 22, 2019	SELL	$86.25 - $120.16 $11,643 - $16,221	-135 Reduced 0.87%	15,440 $1.54 Million
Q2 2019 Jul 30, 2019	SELL	$107.38 - $129.34 $8,053 - $9,700	-75 Reduced 0.48%	15,575 $1.78 Million
Q4 2018 Jan 28, 2019	BUY	$128.36 - $272.13 $33,373 - $70,753	260 Added 1.69%	15,650 $2.12 Million
Q3 2018 Oct 29, 2018	SELL	$211.18 - $274.49 $575,465 - $747,985	-2,725 Reduced 15.04%	15,390 $4.22 Million
Q2 2018 Aug 07, 2018	SELL	$150.77 - $207.98 $214,696 - $296,163	-1,424 Reduced 7.29%	18,115 $3.75 Million
Q1 2018 May 01, 2018	SELL	$138.63 - $182.62 $51,986 - $68,482	-375 Reduced 1.88%	19,539 $3.23 Million
Q4 2017 Jan 30, 2018	SELL	$128.36 - $147.04 $229,764 - $263,201	-1,790 Reduced 8.25%	19,914 $2.73 Million
Q3 2017 Nov 06, 2017	BUY	$120.91 - $137.94 $2.62 Million - $2.99 Million	21,704	21,704 $2.96 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.84B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Court Place Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Court Place Advisors, LLC with notifications on news.

Account

Court Place Advisors, LLC Ligand Pharmaceuticals Inc Transaction History